ModeX Therapeutics
@modextx.bsky.social
UNITING THE POWER OF MULTIPLE MEDICINES IN A SINGLE MOLECULE
Diseases are multi-faceted. We know medicines must be too. Our modular platforms unite the power of multiple biologics into single molecules to combat complex diseases.
https://www.modextx.com/
Diseases are multi-faceted. We know medicines must be too. Our modular platforms unite the power of multiple biologics into single molecules to combat complex diseases.
https://www.modextx.com/
We are excited to announce we have
initiated Phase 1/2a clinical trial (NCT07110584) with MDX2004, a first-in-class trispecific antibody-fusion protein for oncology and immune disorders. See here for more bit.ly/436FmEW
$OPK #multispecifics #antibodies
initiated Phase 1/2a clinical trial (NCT07110584) with MDX2004, a first-in-class trispecific antibody-fusion protein for oncology and immune disorders. See here for more bit.ly/436FmEW
$OPK #multispecifics #antibodies
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers » ModeX Therapeutics
First patient dosed in Phase 1/2a study with novel immune rejuvenator, a trispecific antibody-fusion protein Two MDX2004 abstracts accepted for poster
bit.ly
October 29, 2025 at 1:08 PM
We are excited to announce we have
initiated Phase 1/2a clinical trial (NCT07110584) with MDX2004, a first-in-class trispecific antibody-fusion protein for oncology and immune disorders. See here for more bit.ly/436FmEW
$OPK #multispecifics #antibodies
initiated Phase 1/2a clinical trial (NCT07110584) with MDX2004, a first-in-class trispecific antibody-fusion protein for oncology and immune disorders. See here for more bit.ly/436FmEW
$OPK #multispecifics #antibodies
Don’t miss ModeX Therapeutics’s poster presentation at #ESMO25 and stay at the forefront of research with multispecific antibodies. Learn more about our pipeline here: bit.ly/42LYd80
October 19, 2025 at 5:57 AM
Don’t miss ModeX Therapeutics’s poster presentation at #ESMO25 and stay at the forefront of research with multispecific antibodies. Learn more about our pipeline here: bit.ly/42LYd80
Join Us: #Jefferies Global Healthcare Conference: OPKO Health, Inc. (OPK): www.opko.com/investors/ne...
June 4, 2025 at 3:18 PM
Join Us: #Jefferies Global Healthcare Conference: OPKO Health, Inc. (OPK): www.opko.com/investors/ne...